NRT Smoking Cessation Aids in the US
Contributing to the lacklustre performance of NRT smoking cessation aids in 2014 is the shrinking customer base. Tobacco products are among the most heavily regulated in the US and governing agencies continue to take measures to further reduce smoking prevalence, especially given the tremendous burden of smoking on healthcare. According to a study sponsored by the CDC in 2013, cigarette smoking generates as much as US$170 billion in annual healthcare spending in the US, much of which is paid...
Euromonitor International's NRT Smoking Cessation Aids in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.
Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.